채혈 시장 규모, 점유율, 동향 분석 보고서 : 채혈 부위별, 용도별, 방법별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Blood Collection Market Summary

The global blood collection market size was estimated at USD 5.02 billion in 2025 and is projected to reach USD 8.18 billion by 2033, growing at a CAGR of 6.33% from 2026 to 2033. The market growth is attributed to an increase in the number of diagnostic procedures involving blood samples.

Key procedures include disease screening and medication monitoring. In addition, regular blood tests are necessary for treatment evaluation & monitoring of chronic illnesses, such as diabetes, cardiovascular disease, and cancer. High efficiency and ease in ensuring precise sample collection & preservation make these tests popular among medical experts. The growing prevalence of chronic diseases can further increase the need for diagnostic testing, boosting the demand for blood collection equipment.

Blood samples often require specific temperature conditions (e.g., refrigeration or freezing) to maintain stability and integrity. Ensuring consistent temperature control throughout the storage and transportation is crucial to prevent sample degradation. In addition, coordinating the timely & efficient transportation of samples from collection sites to testing laboratories or facilities is a major challenge in blood collection. For instance, improper transportation of a sample intended for coagulation testing may result in the degradation of clotting factors due to incorrect temperature control. This could potentially lead to inaccurate test results indicating a clotting disorder, resulting in unnecessary anticoagulant therapy for the patient and heightened risks of bleeding complications.

The increasing prevalence of chronic & infectious diseases is a major factor driving the use of blood collection devices. With the U.S. becoming more globalized, health risks transcend borders. Economic integration, industrialization, urbanization, and mass migration contribute to a range of public health challenges. The emergence of infectious diseases, such as COVID-19, has caused significant morbidity & mortality, highlighting the urgent need for effective disease management strategies. Blood collection devices are crucial in diagnosing and monitoring chronic & infectious diseases. They provide a safe, hygienic, and efficient method for collecting samples, ensuring accurate test results & reducing the risk of contamination. In the context of the COVID-19 pandemic, these devices have been essential for collecting samples for diagnostic testing, tracking disease spread, and monitoring patient health.

Global Blood Collection Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood collection market report based on collection site, application, method, end use, and region:

• Collection Site Outlook (Revenue, USD Million, 2021 - 2033)
• Venous
  • Needles and Syringes
  • Double-Ended Needles
  • Winged Blood Collection Sets
  • Standard Hypodermic Needles
  • Other Blood Collection Needles
  • Blood Collection Tubes
  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
  • Blood Bags
  • Others
• Capillary
  • Lancets
  • Micro-Container Tubes
  • Micro-Hematocrit Tubes
  • Warming Devices
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Diagnostics
• Treatment
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Manual Blood Collection
• Automated Blood Collection
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostics Centers
• Blood Banks
• Emergency Departments
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Information Analysis
  • 1.2.2. Market Formulation & Data Visualization
  • 1.2.3. Data Validation & Publishing
• 1.3. Research Assumptions
• 1.4. Information Procurement
  • 1.4.1. Primary Research
• 1.5. Information or Data Analysis
• 1.6. Market Formulation & Validation
• 1.7. Market Model
• 1.8. Global Market: CAGR Calculation
• 1.9. Objective
  • 1.9.1. Objective 1
  • 1.9.2. Objective2

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidences of infectious and non-communicable diseases
    • 3.2.1.2. Rising number of accidental and trauma cases
    • 3.2.1.3. Escalating number of surgical procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risks associated with blood transfusions
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Collection Site Business Analysis

• 4.1. Blood Collection Market: Collection Site Dashboard
• 4.2. Blood Collection Market: Collection Site Movement Analysis
• 4.3. Blood Collection Market by Collection Site, Revenue
• 4.4. Venous
  • 4.4.1. Venous Market, 2021 - 2033 (USD Million)
  • 4.4.2. Needles And Syringes
    • 4.4.2.1. Needles And Syringes Market, 2021 to 2033 (USD Million)
    • 4.4.2.2. Double-Ended Needles
      • 4.4.2.2.1. Double-Ended Needles Market, 2021 to 2033 (USD Million)
    • 4.4.2.3. Winged Blood Collection Sets
      • 4.4.2.3.1. Winged Blood Collection Sets Market, 2021 to 2033 (USD Million)
    • 4.4.2.4. Standard Hypodermic Needles
      • 4.4.2.4.1. Standard Hypodermic Needles Market, 2021 to 2033 (USD Million)
    • 4.4.2.5. Other Blood Collection Needles
      • 4.4.2.5.1. Other Blood Collection Needles Market, 2021 to 2033 (USD Million)
  • 4.4.3. Blood Collection Tubes
    • 4.4.3.1. Blood Collection Tubes Market, 2021 to 2033 (USD Million)
    • 4.4.3.2. Serum-separating Tubes
      • 4.4.3.2.1. Serum-separating Tubes Market, 2021 to 2033 (USD Million)
    • 4.4.3.3. EDTA Tubes
      • 4.4.3.3.1. EDTA Tubes Market, 2021 to 2033 (USD Million)
    • 4.4.3.4. Heparin Tubes
      • 4.4.3.4.1. Heparin Tubes Market, 2021 to 2033 (USD Million)
    • 4.4.3.5. Plasma-separating Tubes
      • 4.4.3.5.1. Plasma-separating Tubes Market, 2021 to 2033 (USD Million)
  • 4.4.4. Blood Bags
    • 4.4.4.1. Blood Bags Market, 2021 to 2033 (USD Million)
  • 4.4.5. Other Blood Collection Sites
    • 4.4.5.1. Other Blood Collection Sites Market, 2021 to 2033 (USD Million)
• 4.5. Capillary
  • 4.5.1. Capillary Market, 2021 - 2033 (USD Million)
  • 4.5.2. Lancets
    • 4.5.2.1. Lancets Market, 2021 to 2033 (USD Million)
  • 4.5.3. Micro-Container Tubes
    • 4.5.3.1. Micro-Container Tubes Market, 2021 to 2033 (USD Million)
  • 4.5.4. Micro-Hematocrit Tubes
    • 4.5.4.1. Micro-Hematocrit Tubes Market, 2021 to 2033 (USD Million)
  • 4.5.5. Warming Devices
    • 4.5.5.1. Warming Devices Market, 2021 to 2033 (USD Million)
  • 4.5.6. Others
    • 4.5.6.1. Others Market, 2021 to 2033 (USD Million)

Chapter 5. Application Method Business Analysis

• 5.1. Blood Collection Market: Application Dashboard
• 5.2. Blood Collection Market: Application Movement Analysis
• 5.3. Blood Collection Market by Application, Revenue
• 5.4. Diagnostics
  • 5.4.1. Diagnostics Market, 2021 - 2033 (USD Million)
• 5.5. Treatment
  • 5.5.1. Treatment Market, 2021 - 2033 (USD Million)

Chapter 6. Method Business Analysis

• 6.1. Blood Collection Market: Method Movement Analysis
• 6.2. Manual Blood Collection
  • 6.2.1. Manual Blood Collection Market, 2021 - 2033 (USD Million)
• 6.3. Automated Blood Collection
  • 6.3.1. Automated Blood Collection Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. Blood Collection Market: End Use Dashboard
• 7.2. Blood Collection Market: End Use Movement Analysis
• 7.3. Blood Collection Market By End Use, Revenue
• 7.4. Hospitals
  • 7.4.1. Hospitals Market, 2021 - 2033 (USD Million)
• 7.5. Diagnostics Centers
  • 7.5.1. Diagnostics Centers Market, 2021 - 2033 (USD Million)
• 7.6. Blood Banks
  • 7.6.1. Blood Banks Market, 2021 - 2033 (USD Million)
• 7.7. Emergency Departments
  • 7.7.1. Emergency Departments Market, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Blood Collection Market Share By Region, 2025 & 2033
• 8.2. North America
  • 8.2.1. North America Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Competitive Scenario
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. U.S. Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Blood Collection Market, 2021 - 2033 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. UK Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Germany Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. France Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Competitive Scenario
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Italy Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Competitive Scenario
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Spain Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.7. Sweden
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Competitive Scenario
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Sweden Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.8. Norway
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Competitive Scenario
    • 8.3.8.3. Regulatory Framework
    • 8.3.8.4. Norway Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.3.9. Denmark
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Competitive Scenario
    • 8.3.9.3. Regulatory Framework
    • 8.3.9.4. Denmark Blood Collection Market, 2021 - 2033 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.2. China
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. China Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.3. India
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. India Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.4. Japan
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Japan Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.5. Thailand
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Thailand Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.6. Australia
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Australia Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.4.7. South Korea
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. South Korea Blood Collection Market, 2021 - 2033 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Brazil Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.5.3. Argentina
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Argentina Blood Collection Market, 2021 - 2033 (USD Million)
• 8.6. MEA
  • 8.6.1. MEA Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.6.2. Saudi Arabia
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Saudi Arabia Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.6.3. South Africa
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. South Africa Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. UAE Blood Collection Market, 2021 - 2033 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Kuwait Blood Collection Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Share Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Abbott
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.1.3. Collection Site Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. NIPRO Medical Corporation
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.2.3. Collection Site Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. BD (Becton, Dickinson and Company)
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.3.3. Collection Site Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Terumo Corporation
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.4.3. Collection Site Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Medtronic
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.5.3. Collection Site Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. QIAGEN
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.6.3. Collection Site Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. FL MEDICAL s.r.l.
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.7.3. Collection Site Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Greiner AG
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.8.3. Collection Site Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Haemonetics Corporation
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.9.3. Collection Site Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. F. Hoffmann-La Roche Ltd.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.10.3. Collection Site Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Sarstedt AG & Co.
    • 9.4.11.1. Overview
    • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.11.3. Collection Site Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Centogene N.V.
    • 9.4.12.1. Overview
    • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.12.3. Collection Site Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. SEKISUI CHEMICAL CO., LTD.
    • 9.4.13.1. Overview
    • 9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.13.3. Collection Site Benchmarking
    • 9.4.13.4. Strategic Initiatives